Page last updated: 2024-09-02
fingolimod hydrochloride and Glaucoma
fingolimod hydrochloride has been researched along with Glaucoma in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Al-Adawy, N; Graham, SL; Gupta, VK; Klistorner, A; Li, JC; You, Y | 1 |
Other Studies
1 other study(ies) available for fingolimod hydrochloride and Glaucoma
Article | Year |
---|---|
FTY720 protects retinal ganglion cells in experimental glaucoma.
Topics: Animals; Blotting, Western; Disease Models, Animal; Fingolimod Hydrochloride; Glaucoma; Immunohistochemistry; Injections, Intraperitoneal; Male; Mitogen-Activated Protein Kinases; Neuroprotective Agents; Night Vision; Ocular Hypertension; Optic Disk; Phosphatidylinositol 3-Kinase; Propylene Glycols; Rats; Rats, Sprague-Dawley; Receptors, Lysosphingolipid; Retina; Retinal Ganglion Cells; Sensory Thresholds; Sphingosine | 2014 |